While this problem may be true of certain poor actors in some fields of science, I would argue that it's far more the exception than the rule.
My experience (in genomics / evolutionary genetics) was overwhelmingly positive, with huge amounts of collaboration all around. Scientists did try to publish at the highest-impact journal because they care about their career prospects, and there were often competitive labs racing to the finish line with a breakthrough publication.
But I never saw researchers withhold important details in order to accelerate their own publication or to hamper the efforts of others. By and large, I saw huge teams collaborating on large projects with a deep sense of purpose to move the field forward and improve understanding.
In fact research funding in genomics became so collaborative — with increasing portions of the research budget being put towards huge consortium-based projects — that smaller labs began criticizing funding agencies because their smaller projects weren't being funded. These projects are typically more competitive and higher risk, yielding potentially high-impact articles with a far smaller number of authors.
What's the answer in the end? As with many things, it's balance. Cooperation is great, but to a fault. Sometimes having small labs working in relative isolation, even competing against other small labs, can yield great innovation and progress. Other times you need a huge collaborative effort to do something big, expensive and important for the future of the field.
My experience (in genomics / evolutionary genetics) was overwhelmingly positive, with huge amounts of collaboration all around. Scientists did try to publish at the highest-impact journal because they care about their career prospects, and there were often competitive labs racing to the finish line with a breakthrough publication.
But I never saw researchers withhold important details in order to accelerate their own publication or to hamper the efforts of others. By and large, I saw huge teams collaborating on large projects with a deep sense of purpose to move the field forward and improve understanding.
In fact research funding in genomics became so collaborative — with increasing portions of the research budget being put towards huge consortium-based projects — that smaller labs began criticizing funding agencies because their smaller projects weren't being funded. These projects are typically more competitive and higher risk, yielding potentially high-impact articles with a far smaller number of authors.
What's the answer in the end? As with many things, it's balance. Cooperation is great, but to a fault. Sometimes having small labs working in relative isolation, even competing against other small labs, can yield great innovation and progress. Other times you need a huge collaborative effort to do something big, expensive and important for the future of the field.